Tag Archives: BIO Official Bloggers Progam

Tony Blair Talks Biotech

From Snapshot At Monday’s keynote luncheon, former British Prime Minister Tony Blair was quizzed about his motives for seeking office and his feelings about the criticism he received for allying with former President Bush. Interesting, but just as I was beginning to wonder if Blair would comment on the biotech industry, he did. Succinctly and with British understatement.  When BIO president Jim Greenwood asked how Blair saw the role of government in advancing biotech, he Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

2011 BIO International Convention: Talent is Talent

From Trade Secrets Even if the total numbers of attendees at BIO is down from its peak, it’s still an incredibly large gathering of diverse people across the biotech spectrum. The exhibit hall is a good reflection of that. I can remember when the hall was just a collection of simple individual company stands – a few employees in a booth, a poster hanging behind them. But as the industry grew, the exhibitors changed; the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

Perspectives from Brazil, India, Argentina, and South Africa

From PharmaTech Talk At this week’s Partnering for Global  Health Forum, sponsored by BIO and BioVentures for Global Health, in Washington, DC, a unique panel of government leaders from emerging markets discussed what it takes to do business in their countries. Among the panelists were: Argentina’s Lino Barañao, Minister of Science, Technology and Innovative Production; India’s Maharaj K. Bhan, Secretary, Department of Biotechnology; South Africa’s Bongi Gumede, Senior General Manager, Technology Innovation and Marketing, Technology Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

Competition gets fierce for innovative science

From FierceBiotech At the height of recession, biotechs were hurting for cash. Big Pharma and its deep pockets were there to cherry-pick the best science at an affordable price from small companies that had little choice but to make deals. But the balance of power has shifted in the past year. Pharma is now face-to-face with the patent cliff, and hardly a week goes by without mention of the industry’s unproductive, yet very costly, R&D Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

FierceBiotech providing live coverage of the 2011 BIO International Convention

FierceBiotech is reporting live from the annual BIO International Convention in Washington, D.C., this week. Check our our BIO 2011 microsite to keep up with news, events and tweets from the show. And if you haven’t already, register now for FierceBiotech’s executive breakfast tomorrow. We’ll examine the issues facing today’s drug developers as they navigate the challenges involved in obtaining FDA approval. Read more from John’s blog (one of our official bloggers): Live from BIO: Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,